UnknownPHASE2, PHASE3NCT02045069

Efficacy and Safety of Ivermectin Against Dengue Infection

Studying Dengue fever

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Mahidol University
Principal Investigator
Panisadee Avirutnan, MD, PhD.
Division of Dengue Hemorrhagic Fever Research Department of Research and Development, Faculty of Medicine Siriraj Hospital Mahidol University, Bangkok 10700, THAILAND
Intervention
2 days Ivermectin(drug)
Enrollment
360 enrolled
Eligibility
15 years · All sexes
Timeline
2014 – 2016

Study locations (1)

Collaborators

Ministry of Health, Thailand

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02045069 on ClinicalTrials.gov

Other trials for Dengue fever

Additional recruiting or active studies for the same condition.

See all trials for Dengue fever →

← Back to all trials